Tokalas TK216-01 (Sarcoma) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to find out how safe and if the study drug (TK216) will work in patients with Ewing Sarcoma.
Who Can Participate in the Study?
Adults with a diagnosis of Ewing Sarcoma whose cancer has gotten worse with standard therapy.
What is Involved?
If you choose to join this study, you will:
Be involved in two parts: Screening and Treatment
During Screening, you will have:
- A physical exam
- A urine sample
- Several imaging tests
During Treatment, you will:
- Be admitted to hospital to get study drug
- Get the study drug (TK216), infused through a central line (an I.V.) until your cancer gets worse, or the study doctor takes you off of the study